The most practical screening tool for detecting mild cognitive impairment in primary care is the Montreal Cognitive Assessment. Ziad Nasreddine at McGill University developed the test to be more sensitive to early cognitive changes than older instruments. In clinical practice the MoCA is widely used because it samples executive function, attention, and visuospatial skills that often decline early in mild impairment, whereas the Mini-Mental State Examination is less sensitive to those domains and tends to miss subtle deficits.
Why the MoCA is preferred
The MoCA was designed as a brief, structured screen that clinicians can administer in roughly ten minutes. It was validated by Nasreddine and colleagues against clinical diagnosis and found to detect cognitive change that the MMSE frequently overlooked. Because it covers a broader range of cognitive domains, the MoCA better identifies the pattern of deficits typical of early Alzheimer disease, vascular cognitive impairment, and other common causes of mild decline. Early identification matters: detecting impairment while function remains largely preserved opens the window for risk-factor management, medication review, treatment of reversible contributors such as thyroid disease or depression, and planning with patients and families.
Practical, cultural, and territorial nuances
Use of the MoCA requires attention to education and language. The instrument includes an education adjustment—one additional point is commonly applied for individuals with twelve years of education or less—to reduce false positives. Validated translations and culturally adapted versions exist, but local normative data are often limited; clinicians working with Indigenous, immigrant, or rural populations should interpret scores with caution and combine testing with clinical history and informant reports. Access to follow-up neuropsychological testing and specialist referral varies by region, so primary care teams play a crucial role in initiating assessment and coordinating care where resources are constrained.
Because screening is only a first step, clinicians must remember that a positive MoCA is not a diagnosis; it signals the need for further evaluation for causes that include neurodegenerative disease, cerebrovascular injury, medication effects, sensory loss, and psychiatric conditions. Integrating the MoCA into routine practice improves detection of mild cognitive impairment when used alongside careful history, collateral information, and appropriate local referral pathways.